Register Login
Register to leave comments
  • News bot Sept. 1, 2026, 8:25 p.m.

    📋 EMERGENT BIOSOLUTIONS INC. (EBS) - Clinical Trial Update

    Filing Date: 2026-09-01

    Accepted: 2026-09-01 16:13:12

    Event Type: Clinical Trial Update

    Event Details:

    EMERGENT BIOSOLUTIONS INC. (EBS) Announces Clinical Trial Update EMERGENT BIOSOLUTIONS INC. (EBS) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: implications, Million
    • Diseases/Conditions: CYFENDUS® (Anthrax Vaccine Adsorbed
    • Collaboration: the Biomedical Advanced Research and Development Authority
    • Updated Timeline: July 2023

    🔬 Clinical Development Pipeline (EMERGENT BIOSOLUTIONS INC.):

    Product Type Development Stage Therapeutic Area Source
    8 mg naloxone NARCAN Nasal Spray Other Phase PHASE1 Opioid Overdose ClinicalTrials.gov
    16 mg naloxone AP003 Other Phase PHASE1 Opioid Overdose ClinicalTrials.gov
    VIGIV Other Preclinical Complication of Smallpox Vaccination ClinicalTrials.gov
    BioThrax Other Phase PHASE3 Anthrax ClinicalTrials.gov
    AV7909 Other Phase PHASE3 Anthrax ClinicalTrials.gov
    Placebo Other Phase PHASE1 Zika Virus Infection ClinicalTrials.gov
    Zika Virus Immune Globulin (ZIKV-IG) Other Phase PHASE1 Zika Virus Infection ClinicalTrials.gov
    UFluA 60 µg each antigen/dose Other Phase PHASE1 Human Influenza ClinicalTrials.gov
    UFluA 20 µg each antigen/dose Other Phase PHASE1 Human Influenza ClinicalTrials.gov
    Prednisone Other Phase PHASE2 Arthritis, Rheumatoid ClinicalTrials.gov
    Methylprednisolone Other Phase PHASE2 Arthritis, Rheumatoid ClinicalTrials.gov
    TRU-015 Other Phase PHASE2 Arthritis, Rheumatoid ClinicalTrials.gov
    MVA85A Other Phase PHASE1 Tuberculosis ClinicalTrials.gov
    AERAS-402 Other Phase PHASE1 Tuberculosis ClinicalTrials.gov
    Raxibacumab Other Phase PHASE2 Therapeutic Treatment of Inhalation Anthrax ClinicalTrials.gov
    VLA1601 Other Phase PHASE1 Zika Virus ClinicalTrials.gov
    Shanchol Other Phase PHASE2 Cholera ClinicalTrials.gov
    PXVX0200 10E9 Other Phase PHASE2 Cholera ClinicalTrials.gov
    PXVX0200 10E8 Other Phase PHASE2 Cholera ClinicalTrials.gov
    gp 120 Protein Boost Other Phase PHASE1 Vaccine Response ClinicalTrials.gov
    Ad4-EnvC150 Other Phase PHASE1 Vaccine Response ClinicalTrials.gov
    Ad4-mgag Other Phase PHASE1 Vaccine Response ClinicalTrials.gov
    PXVX0200 Other Phase PHASE1 Cholera ClinicalTrials.gov
    VAXCHORA (Cholera Vaccine, Live, Oral) Other Phase PHASE4 Cholera (Disorder) ClinicalTrials.gov
    PXVX0200 Lot C Other Phase PHASE3 Cholera ClinicalTrials.gov
    PXVX0200 Lot B Other Phase PHASE3 Cholera ClinicalTrials.gov
    PXVX0200 Lot A Other Phase PHASE3 Cholera ClinicalTrials.gov
    CHIKV VLP, adjuvanted Other Phase PHASE2 Chikungunya Virus ClinicalTrials.gov
    CHIKV VLP/adjuvanted Other Phase PHASE2 Chikungunya Virus Infection ClinicalTrials.gov
    CHIKV VLP/unadjuvanted Other Phase PHASE2 Chikungunya Virus Infection ClinicalTrials.gov
    Vivotif Other Preclinical Typhoid Fever ClinicalTrials.gov
    BAT Other Preclinical Botulism ClinicalTrials.gov
    Observational Intervention Other Preclinical Pregnancy Complications ClinicalTrials.gov
    AVP-21D9 Other Phase PHASE1 Anthrax ClinicalTrials.gov
    Placebo for FLU-IGIV Other Phase PHASE2 Influenza A H3N2 ClinicalTrials.gov
    FLU-IGIV Other Phase PHASE2 Influenza A H3N2 ClinicalTrials.gov
    Teva Ad4/Ad7 Vaccine Other Phase PHASE1 Adenoviral Infection ClinicalTrials.gov
    PXVX0047 Vaccine Other Phase PHASE1 Adenoviral Infection ClinicalTrials.gov
    AIDSVAX B/E Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Placebo Comparator Other Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    UV-4B Y mg (dose to be determined) oral solution Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    UV-4B X mg (dose to be determined) oral solution Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    UV-4B 150 mg oral solution Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    UV-4B 75 mg oral solution Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    UV-4B 30 mg oral solution Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    Vaccination with ACAM2000 Other Phase PHASE4 Smallpox Vaccine Adverse Reaction ClinicalTrials.gov
    Diphenhydramine Other Phase PHASE4 Infections, Bacterial ClinicalTrials.gov
    AVA Other Phase PHASE4 Infections, Bacterial ClinicalTrials.gov
    UV-4B 1000 mg Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    UV-4B 720 mg Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    UV-4B 360 mg Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    UV-4B 180 mg Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    UV-4B 90 mg Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    UV-4B 30 mg Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    UV-4B 10 mg Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    UV-4B 3 mg Other Phase PHASE1 Viral Infection ClinicalTrials.gov
    Ad4-PA-GPI-1 Other Phase PHASE1 Anthrax Infection ClinicalTrials.gov
    Ad4-PA-1 Other Phase PHASE1 Anthrax Infection ClinicalTrials.gov
    hepatitis B vaccine Other Phase PHASE3 Healthy Volunteers ClinicalTrials.gov
    Control Other Phase PHASE1 Bacillus Anthracis (Anthrax) Infection ClinicalTrials.gov
    AV7909 Formulation 4 Other Phase PHASE1 Bacillus Anthracis (Anthrax) Infection ClinicalTrials.gov
    AV7909 Formulation 3 Other Phase PHASE1 Bacillus Anthracis (Anthrax) Infection ClinicalTrials.gov
    AV7909 Formulation 2 Other Phase PHASE1 Bacillus Anthracis (Anthrax) Infection ClinicalTrials.gov
    AV7909 Formulation 1 Other Phase PHASE1 Bacillus Anthracis (Anthrax) Infection ClinicalTrials.gov
    ACAM2000 Other Phase PHASE3 Smallpox Vaccine Adverse Reaction ClinicalTrials.gov
    Sanofi Pasteur Influenza Virus Vaccine, H5N1 Other Phase PHASE1 Bird Flu ClinicalTrials.gov
    Ad4-H5-Vtn Other Phase PHASE1 Bird Flu ClinicalTrials.gov
    CHIKV VLP/adjuvant Other Phase PHASE3 Chikungunya Virus ClinicalTrials.gov
    Chikungunya Other Phase PHASE2 Chikungunya ClinicalTrials.gov
    Brincidofovir Other Phase PHASE1 Smallpox ClinicalTrials.gov
    Stabilized Isoamyl Nitrite (SIAN) Other Phase PHASE1 Cyanide Poisoning ClinicalTrials.gov
    COVID-HIG Other Phase PHASE1 SARS-CoV-2 Infection ClinicalTrials.gov
    Placebo (saline) Other Phase PHASE1 COVID-19 ClinicalTrials.gov
    COVID-HIGIV Other Phase PHASE1 COVID-19 ClinicalTrials.gov
    Ciprofloxacin Other Phase PHASE2 Anthrax ClinicalTrials.gov
    Doxycycline 100Mg Tablet Other Phase PHASE2 Anthrax ClinicalTrials.gov
    Ciprofloxacin 500Mg Tablet Other Phase PHASE2 Anthrax ClinicalTrials.gov
    Blood sample collection Other Phase PHASE4 Botulism ClinicalTrials.gov
    Collection of samples BIOLOGICAL Preclinical Infections, Bacterial ClinicalTrials.gov
    CYFENDUS BIOLOGICAL Preclinical Anthrax ClinicalTrials.gov
    AIGIV DRUG Preclinical Inhalational Anthrax ClinicalTrials.gov
    Sample Collection BIOLOGICAL Phase PHASE4 Infections, Bacterial ClinicalTrials.gov
    ACAM2000® smallpox vaccine BIOLOGICAL Preclinical Smallpox ClinicalTrials.gov
    CHOP DRUG Phase PHASE2 T-cell Lymphoma ClinicalTrials.gov
    CHOP + CD4 BIOLOGICAL Phase PHASE2 T-cell Lymphoma ClinicalTrials.gov
    HuMax-CD4 BIOLOGICAL Phase PHASE2 T Cell Lymphoma ClinicalTrials.gov
    Gamunex 360 mg/kg BIOLOGICAL Phase PHASE1 Anthrax ClinicalTrials.gov
    AIGIV 14.0 mg/kg BIOLOGICAL Phase PHASE1 Anthrax ClinicalTrials.gov
    Gamunex 180 mg/kg BIOLOGICAL Phase PHASE1 Anthrax ClinicalTrials.gov
    AIGIV 7.0 mg/kg BIOLOGICAL Phase PHASE1 Anthrax ClinicalTrials.gov
    Gamunex 90 mg/kg BIOLOGICAL Phase PHASE1 Anthrax ClinicalTrials.gov
    AIGIV 3.5 mg/kg BIOLOGICAL Phase PHASE1 Anthrax ClinicalTrials.gov
    Placebo (Cohorts 1-4 pooled) OTHER Phase PHASE2 Typhoid ClinicalTrials.gov
    Dose of of 1.7 x 10^10 CFU (Cohort 4) BIOLOGICAL Phase PHASE2 Typhoid ClinicalTrials.gov
    Dose of 1.1 x 10^10 CFU (Cohort 3) BIOLOGICAL Phase PHASE2 Typhoid ClinicalTrials.gov
    Dose of 7.5 x 10^9 CFU (Cohort 2) BIOLOGICAL Phase PHASE2 Typhoid ClinicalTrials.gov
    Dose of 5.0 x 10^9 CFU (Cohort 1) BIOLOGICAL Phase PHASE2 Typhoid ClinicalTrials.gov
    Botulism Antitoxin Heptavalent (Equine) Types A-G BIOLOGICAL Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Botulism Antitoxin Bivalent (Equine) Types A and B BIOLOGICAL Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    NP-015 BIOLOGICAL Phase PHASE1 Symptoms of Inhalational Anthrax ClinicalTrials.gov
    Botulinum Antitoxin Heptavalent (A B C D E F G) - (EQUINE) BIOLOGICAL Phase PHASE1 Healthy ClinicalTrials.gov
    vaccinia virus (calf lymph): Dryvax BIOLOGICAL Phase PHASE2 Smallpox ClinicalTrials.gov
    Vaccinia virus: ACAM2000 smallpox vaccine BIOLOGICAL Phase PHASE2 Smallpox ClinicalTrials.gov
    Vaccinia virus (calf lymph) smallpox vaccine: Dryvax® BIOLOGICAL Phase PHASE2 Smallpox ClinicalTrials.gov
    ACAM2000 Smallpox Vaccine BIOLOGICAL Phase PHASE2 Smallpox ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: EMERGENT BIOSOLUTIONS INC.
    • Ticker Symbol: EBS

Search

News categories